VitaNova Life Sciences (VNOV) Shareholder's Equity Growth (5y) (2022 - 2026)

VitaNova Life Sciences (VNOV) Shareholder's Equity Growth (5y) (2022 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 VitaNova Life Sciences - - 316,343.00

Historic Data

Download Data
DateValue
Jan 31, 2026 70.56%
Oct 31, 2025 71.84%
Jul 31, 2025 73.93%
Apr 30, 2025 77.40%
Jan 31, 2025 69.56%
Oct 31, 2024 68.40%
Jul 31, 2024 74.72%
Apr 30, 2024 87.24%
Jan 31, 2024 91.51%
Oct 31, 2023 -350.05%
Jul 31, 2023 -38.90%
Apr 30, 2023 -27.77%
Jan 31, 2023 -26.06%
Oct 31, 2022 -20.23%
Apr 30, 2022 -56.94%